M. Giuliano et al., The apoptotic effects and synergistic interaction of sodium butyrate and MG132 in human retinoblastoma Y79 cells, CANCER RES, 59(21), 1999, pp. 5586-5595
This study deals with the apoptotic effect exerted on human retinoblastoma
Y79 cells by both sodium butyrate and an inhibitor of 26S proteasome [z-Leu
-Leu-Leu-CHO (MG132)] and their synergistic effect. Exposure to sodium buty
rate (1-4 mM) induced an accumulation of cells in the G(2)-M phase that was
already visible after 24 h of treatment, when morphological and biochemica
l signs of apoptosis appeared only in a small number of cells (5-10%). Ther
eafter, the apoptotic effects increased progressively with slow kinetics, r
eaching a maximum after 72 h of exposure, when they concerned a large fract
ion of cells (>75% with 4 mM sodium butyrate). Sodium butyrate stimulated t
he conversion of procaspase-3 into caspase-3 and also induced the cleavage
of poly-(ADP-ribose) polymerase and lamin a, two hallmarks of apoptosis. Al
l of the apoptotic signals were suppressed by benzyloxy carbonyl-Val-Ala-As
p-fluoromethylketone (a general inhibitor of caspase activities), whereas a
cetyl-Asp-Glu-Val-Asp aldehyde, a specific inhibitor of caspase-3 activity,
only induced a partial reversion of the apoptotic effects. Sodium butyrate
also decreased the Bcl-2 level, whereas it increased the Bar level and sti
mulated the release of cytochrome c from the mitochondria, an event that wa
s most likely responsible for the activation of caspase-3. Finally, sodium
butyrate activated 26S proteasome, the major extralysosomal degradative mac
hinery, which is responsible for the degradation of short-lived proteins. C
onsequently, the levels of p53, N-myc, and I kappa B alpha (factors that pl
ay regulatory roles in apoptosis) diminished, whereas the nuclear level of
nuclear factor KB concomitantly increased, Treatment of Y79 cells with MG13
2 induced apoptosis with more rapid kinetics than with sodium butyrate. The
effects appeared after 8 h of incubation, reaching a maximum at 24 h, and
they were accompanied by increased levels of N-myc, p53, and I kappa B alph
a. MG132 also favored the release of cytochrome c from the mitochondria and
Increased the activity of caspase-3. When Y79 cells were exposed to combin
ations of sodium butyrate and MG132, the Latter compound suppressed the dec
reasing effect induced by sodium butyrate on the levels of p53, N-myc, and
IkB alpha and the increasing effect on the nuclear level of nuclear factor
kappa B. Moreover, an increase in the level of Bax and an enhancement in th
e release of cytochrome c from the mitochondria were observed, Clear synerg
istic effects concerning the activation of both caspase-3 and apoptosis wer
e induced by a combination of suboptimal doses of sodium butyrate and MG132
. The results support the conclusion that MG132 potentiates the apoptotic e
ffect of sodium butyrate by suppressing its stimulatory effect on 26S prote
asome activity. Synergistic interactions between butyrate and inhibitors of
proteasome could represent a new important tool in tumor therapy and, in p
articular, the treatment of retinoblastoma.